2024-04-02 Conversion | 2024-04-04 4:30 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 4,851,442 | $0 | 1,181,766 (Indirect) | View |
Ownership | 2024-03-27 7:56 pm | N/A N/A | Boundless Bio Inc. | BOLD | CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT GILLIS STEVEN 10% Owner | 0 | $0 | 2,494,095 (Indirect) | View |
2023-12-08 Other | 2023-12-12 7:53 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 1,879,654 | $0 | 32,424,564 (Indirect) | View |
2023-09-19 Conversion | 2023-09-20 06:16 am | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 17,424,704 | $0 | 3,624,143 (Indirect) | View |
Ownership | 2023-09-14 9:29 pm | N/A N/A | Neumora Therapeutics Inc. | NMRA | ARCH Venture Partners X LLC ARCH Venture Partners XII LLC ARCH Venture Partners XII L.P. ARCH Venture Fund XII L.P. CRANDELL KEITH GILLIS STEVEN NELSEN ROBERT BYBEE CLINTON 10% Owner | 0 | $0 | 28,045,420 (Indirect) | View |
2022-09-02 Other | 2022-09-07 8:29 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,035,018 | $0 | 1,126,748 (Indirect) | View |
2022-08-30 Other | 2022-09-01 5:20 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,035,006 | $0 | 1,117,864 (Indirect) | View |
2022-08-24 Other | 2022-08-26 5:12 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,035,006 | $0 | 1,109,010 (Indirect) | View |
2022-08-18 Other | 2022-08-22 5:14 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,503 | $0 | 582,653 (Indirect) | View |
2022-08-12 Other | 2022-08-16 9:04 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,552,509 | $0 | 1,613,232 (Indirect) | View |
2022-06-08 Other | 2022-06-10 9:27 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,503 | $0 | 564,945 (Indirect) | View |
2022-06-02 Other | 2022-06-06 8:24 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,502 | $0 | 10,955,581 (Indirect) | View |
2021-12-20 Other | 2021-12-22 5:59 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,811,207 | $0 | 12,527,079 (Indirect) | View |
2021-11-29 Other | 2021-12-01 6:30 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,485 | $0 | 12,205,620 (Indirect) | View |
2021-11-22 Other | 2021-11-24 5:58 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 517,485 | $0 | 12,483,411 (Indirect) | View |
2021-07-01 Other | 2021-07-06 4:47 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 4,033,412 | $0 | 16,277,129 (Indirect) | View |
2021-06-30 Other | 2021-07-02 5:19 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 208,052 | $0 | 3,357,682 (Indirect) | View |
2021-06-25 Other | 2021-06-29 5:22 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT 10% Owner | 416,104 | $0 | 3,961,048 (Indirect) | View |
2021-06-22 Other | 2021-06-24 5:03 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,008,348 | $0 | 15,501,684 (Indirect) | View |
2021-06-21 Conversion | 2021-06-23 5:42 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | ARCH Venture Partners IX LLC ARCH Venture Fund IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 54,619,074 | $0 | 18,206,358 (Indirect) | View |
Ownership | 2021-06-16 9:00 pm | N/A N/A | Lyell Immunopharma Inc. | LYEL | ARCH Venture Partners IX LLC ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Partners IX L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 0 | $0 | 36,412,716 (Indirect) | View |
2021-04-13 Other | 2021-04-15 5:18 pm | N/A N/A | Karuna Therapeutics Inc. | KRTX | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner | 76,264 | $0 | 1,608,617 (Indirect) | View |
2021-04-07 Other | 2021-04-09 5:07 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,008,360 | $0 | 16,064,106 (Indirect) | View |
2021-03-31 Other | 2021-04-02 3:19 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 203,366 | $0 | 3,927,319 (Indirect) | View |
2021-03-30 Other | 2021-04-01 5:24 pm | N/A N/A | Vir Biotechnology Inc. | VIR | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 1,008,350 | $0 | 16,626,496 (Indirect) | View |
2021-03-18 Other | 2021-03-22 7:34 pm | N/A N/A | Beam Therapeutics Inc. | BEAM | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. CRANDELL KEITH BYBEE CLINTON 10% Owner | 406,731 | $0 | 4,529,873 (Indirect) | View |
2021-02-08 Conversion | 2021-02-10 7:22 pm | N/A N/A | Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner | 65,625,000 | $0 | 11,718,750 (Indirect) | View |
Ownership | 2021-02-03 9:30 pm | N/A N/A | Sana Biotechnology Inc. | SANA | ARCH Venture Fund X L.P. CRANDELL KEITH BYBEE CLINTON Burow Kristina GILLIS STEVEN 10% Owner | 0 | $0 | 44,042,500 (Indirect) | View |
2021-01-08 Other | 2021-01-12 4:44 pm | N/A N/A | Karuna Therapeutics Inc. | KRTX | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner | 76,264 | $0 | 1,683,311 (Indirect) | View |
2020-12-22 Conversion | 2020-12-22 8:28 pm | N/A N/A | 908 Devices Inc. | MASS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC BYBEE CLINTON NELSEN ROBERT 10% Owner | 10,850,090 | $0 | 5,725,045 (Direct) | View |
Ownership | 2020-12-17 8:03 pm | N/A N/A | 908 Devices Inc. | MASS | ARCH Venture Fund VII L.P. ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC BYBEE CLINTON NELSEN ROBERT 10% Owner | 0 | $0 | 5,425,045 (Direct) | View |
2020-11-20 Other | 2020-11-24 8:59 pm | N/A N/A | Quanterix Corp | QTRX | ARCH VENTURE FUND VI LP ARCH Venture Fund VIII Overage L.P. ARCH VENTURE PARTNERS VI LP ARCH VENTURE PARTNERS VI LLC ARCH Venture Partners VIII LLC BYBEE CLINTON NELSEN ROBERT 10% Owner | 833,211 | $0 | 2,049,870 (Indirect) | View |
2020-11-12 Other | 2020-11-16 6:14 pm | N/A N/A | Karuna Therapeutics Inc. | KRTX | ARCH Venture Partners IX LLC ARCH Venture Partners IX L.P. ARCH Venture Partners IX Overage L.P. ARCH Venture Fund IX L.P. ARCH Venture Fund IX Overage L.P. BYBEE CLINTON CRANDELL KEITH 10% Owner | 76,264 | $0 | 1,758,005 (Indirect) | View |
2020-10-23 Exercise | 2020-10-23 6:13 pm | N/A N/A | IMPINJ INC | PI | BYBEE CLINTON Director | 3,411 | $0 | 17,125 (Direct) | View |
2020-10-16 Conversion | 2020-10-20 8:07 pm | N/A N/A | Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner | 30,658,565 | $0 | 2,503,903 (Indirect) | View |
Ownership | 2020-10-13 9:23 pm | N/A N/A | Codiak BioSciences Inc. | CDAK | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner | 0 | $0 | 3,620,109 (Indirect) | View |
2020-09-18 Conversion | 2020-09-22 11:07 am | N/A N/A | Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner | 2,710,503 | $0 | 158,734 (Indirect) | View |
Ownership | 2020-09-15 5:07 pm | N/A N/A | Metacrine Inc. | MTCR | ARCH Venture Fund VIII L.P. ARCH Venture Fund VIII Overage L.P. CRANDELL KEITH BYBEE CLINTON NELSEN ROBERT ARCH Venture Partners VIII LLC ARCH Venture Partners VIII L.P. 10% Owner | 0 | $0 | 2,710,503 (Indirect) | View |